Get the Stockscreener App
7.79
9.52%
-0.82
After Hours:
7.52
-0.27
-3.47%
Sonnet Biotherapeutics Holdings Inc stock is traded at $7.79, with a volume of 2.20M.
It is down -9.52% in the last 24 hours and up +571.55% over the past month.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
See More
Previous Close:
$8.61
Open:
$8.11
24h Volume:
2.20M
Relative Volume:
0.64
Market Cap:
$24.66M
Revenue:
$129.20K
Net Income/Loss:
$-7.44M
P/E Ratio:
-0.6962
EPS:
-11.19
Net Cash Flow:
$-8.62M
1W Performance:
+47.54%
1M Performance:
+571.55%
6M Performance:
+405.84%
1Y Performance:
+8.19%
1-Day Range:
$7.14
$8.57
1-Week Range:
$4.8607
$19.30
52-Week Range:
$1.08
$19.30
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Company Profile
Name
Sonnet Biotherapeutics Holdings Inc
Sector
Industry
Phone
609-375-2227
Address
100 OVERLOOK CENTER, PRINCETON, NJ
Compare SONN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SONN
Sonnet Biotherapeutics Holdings Inc
|
7.79 | 14.69M | 129.20K | -7.44M | -8.62M | -11.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.27 | 123.00B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.00 | 59.66B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.69 | 41.84B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
572.71 | 33.98B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
290.35 | 27.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Latest News
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Sonnet BioTherapeutics Bets Big on HYPE Token as Charts Signal 161% Rally Potential - CoinChapter
Sonnet BioTherapeutics’ New Strategy with $888 Million Worth of Crypto Reserves! - Pintu
Hyperliquid Strategies Inc. plan for $583M treasury boosts HYPE price - Cointelegraph
Sonnet BioTherapeutics Announces $888M Combination With Rorschach For HYPE Treasury - Tekedia
Biotech Firm Sonnet Pivots to Crypto Treasury Strategy in $888M HYPE Token Deal - blockhead.co
What makes Sonnet BioTherapeutics Holdings Inc. stock price move sharplyLow Risk Trading Ideas - Newser
Why Sonnet BioTherapeutics Holdings Inc. stock attracts strong analyst attentionHigh Probability Setups - Newser
How Sonnet BioTherapeutics Holdings Inc. stock performs during market volatilityFree Stock Portfolio Optimization - Newser
Sonnet BioTherapeutics Launches $888M Crypto Treasury Strategy - The Crypto Times
Sonnet BioTherapeutics Announces Merger with Rorschach I LLC - The Globe and Mail
Crypto Deal Boosts Sonnet BioTherapeutics Share Price By 260% - Happy Coin News
Sonnet BioTherapeutics Merges in $888M Deal to Launch Hyperliquid Strategies and HYPE Treasury - The Currency analytics
PLTR, TTD, TLRY, SONN, TSLA: 5 Trending Stocks TodaySonnet BioTherapeutics (NASDAQ:SONN), Palantir Technologies (NASDAQ:PLTR) - Benzinga
Hyperliquid's Price Drops 2.82% Amid Nasdaq Listing Through Sonnet BioTherapeutics Merger - AInvest
Small Healthcare Stocks Enjoy Big Wins On Deal News - Finimize
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, KLG, MRGM, SONN on Behalf of Shareholders - GlobeNewswire Inc.
Sonnet BioTherapeutics Stock Jumps 82% After Deal With Rorschach I: Retail Stays Exuberant - Stocktwits
Sonnet BioTherapeutics Holdings Inc (SONN) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com
Atlas Merchant Capital LLC entered into a definitive agreement to acquire Sonnet BioTherapeutics Holdings, Inc. in a reverse merger transaction. - MarketScreener
Massive deal sends biotech stock rallying 367% - Yahoo Finance
Sonnet BioTherapeutics Agrees $888M Merger as It Launches Strategic HYPE Treasury - NFTgators
Hyperliquid Strategies Inc. to Hold $583 Million in HYPE Tokens Post Merger - AInvest
New Nasdaq-Listed Company, Hyperliquid Strategies, to Hold $583M in HYPE Tokens - CryptoRank
Crude Oil Moves Lower; Daré Bioscience Shares JumpDiginex (NASDAQ:DGNX), Dare Bioscience (NASDAQ:DARE) - Benzinga
Sonnet Biotherapeutics shares surge 59.85% intraday after announcing an $888 million business combination to launch a HYPE cryptocurrency treasury reserve strategy. - AInvest
HYPE coin price up 200%, Sonnet BioTherapeutics merges into Hyperliquid Strategies - Invezz
Why Is Sonnet BioTherapeutics Stock Trading Higher On Monday? - Benzinga
Sonnet ditches biotech dreams to anchor a $583m HYPE token reserve - Crypto News
Sonnet BioTherapeutics Merges with Rorschach I to Form Hyperliquid Strategies Inc. Stock Surges 200% - AInvest
Sonnet BioTherapeutics Spikes 153% on $888 Million Deal with Rorschach - Wall Street Pit
Sonnet BioTherapeutics, Inc. Stock Soars 218% Amid $888M Hyperliquid Merger Deal - CoinCentral
Sonnet BioTherapeutics Surge: What’s Fueling the Rise? - StocksToTrade
US Stocks Edge Lower; Fastenal Posts Upbeat Earnings - Benzinga
Sonnet BioTherapeutics Merges to Launch Hyperliquid Strategies - Crypto Economy
Why did Sonnet BioTherapeutics (SONN) Shares Gain over 200% in Premarket Trading? - Tokenist
Is Sonnet BioTherapeutics Stock A Hidden Gem? - timothysykes.com
Sonnet BioTherapeutics Pivots to Cryptocurrency with $888 Million Deal - AInvest
SONN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Sonnet BioTherapeutics, Inc. Is Fair to Shareholders - Business Wire
Sonnet BioTherapeutics stock soars after $888 million crypto deal By Investing.com - Investing.com Nigeria
Sonnet BioTherapeutics Soars 290.33% on Strategic Business Combination - AInvest
Sonnet BioTherapeutics Joins Forces With Rorschach For Big Merger - Finimize
Nasdaq-listed Sonnet BioTherapeutics agrees to $888 million merger to become Hyperliquid Strategies, launch HYPE treasury - The Block
Sonnet Biotherapeutics, Inc. announces $888 million business combination to launch a hype cryptocurrency treasury reserve strategy - MarketScreener
Sonnet BioTherapeutics agrees to $888 million crypto treasury deal By Investing.com - Investing.com Nigeria
Sonnet BioTherapeutics jumps over 320%, combines business for HYPE crypto reserve (SONN:NASDAQ) - Seeking Alpha
Sonnet BioTherapeutics to merge, creating $888m crypto treasury By Investing.com - Investing.com Canada
Sonnet BioTherapeutics, Inc. Announces $888 Million - GlobeNewswire
Massive $888M Deal: Biotech Firm Makes Historic Pivot to Become Largest US Public HYPE Token Holder - Stock Titan
Lowenstein Represents Sonnet BioTherapeutics, Inc. in Agreement to Launch $888M HYPE Cryptocurrency Treasury Reserve Strategy - Lowenstein Sandler LLP
Sonnet BioTherapeutics Pivots Into Crypto With $888M Hyperliquid Treasury Strategy - Bitget
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):